Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with knee osteoarthritis rated at a certain level of severity (stage 2 to 4 on a standard medical scale), confirmed by a knee X-ray taken within the past 3 years.
- People whose knee osteoarthritis causes significant difficulty with physical activities, as measured by a standard questionnaire score (confirm with trial site for exact score threshold).
- People for whom the treating doctor is willing to prescribe a spa therapy program at the Rheumatology department in Santenay spa as part of their knee osteoarthritis treatment.
- People who have signed an informed consent form agreeing to take part.
- People who have health insurance coverage.
Who may not be able to join:
- People who have a medical condition that makes spa therapy or related treatments (such as water therapy, jets, or massage) unsafe — for example, serious ongoing infections, active cancer, severe heart, liver or kidney problems, open leg ulcers, immune system disorders, blood clots, or certain behavioural conditions (confirm full list with trial site).
- People who have ongoing chronic pain caused by conditions other than osteoarthritis, such as rheumatoid arthritis, ankylosing spondylitis, lupus, psoriatic arthritis, or fibromyalgia.
- People who have had spa therapy treatment in the past 6 months, a steroid injection into a joint within the past 90 days, or a hyaluronic acid injection into a joint within the past 6 months.
- People who have another spa treatment planned for any reason between joining the trial and the final study visit.
- People who have knee surgery planned within the next 7 months.
- People who live more than 30 kilometres from Santenay at the time of the spa treatment.
- Women who are able to become pregnant and are not using an effective form of hormonal contraception, or who plan to stop using contraception within the next 7 months.
- People who are unlikely to be able to follow the study requirements or attend all appointments, or who are unable to read or understand French.
- People who are under legal guardianship or who are currently enrolled in another clinical trial, or are still within an exclusion period from a previous clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bruno COLLOMBIER, MD
Phone: +33380680511
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Minimal Clinically Important Improvement (MCII) at 6 months; Minimal Clinically Important Improvement (MCII) at 6 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.